Beijing Jinlan Gene Technology Co., Ltd. is a Chinese company located in Beijing. The firm operates as a drug development company. It was founded in 2018 by Xiao Yan Dong, Guo Qing Liu and Xiao Bing Wu.

Daewoo Pharmaceutical Ind Co. Ltd. is a private company headquartered in the South Korea. The firm manufactures pharmaceutical products.

MD Healthcare, Inc. is engaged in developing innovative precision medical solutions based on micro biome data. The company was founded in January, 2014 and is headquartered in Seoul, South Korea.

Beikang Medical Technology Co., Ltd., established on 2021-03-04, Business scope includes licensed projects:pharmaceutical production;Drug Wholesale;Production of Class II Medical Devices;Technology Import and Export;Import and export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical Research and Experimental Development;R&D and application of cell technology;Human stem cell technology development and application;Research and development of bio-based materials technology;Sales of Class I Medical Devices;Production of Class I Medical Devices;Sales of Class II Medical Devices(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Shengtai Yingnuo (Jiaxing) Medical Technology Co., Ltd., established on 2019-08-23, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Health Consulting Services(Does not include medical services);Sales of Class I Medical Devices;Sales of Class II Medical Devices;Chemical product sales(No licensed chemical products);Experimental analysis instrument sales;Medical Research and Experimental Development;Cosmetics Wholesale;Cosmetics Retail;Sales of bio-based materials;Mold Sales;Production of Class I Medical Devices;Instrument Manufacturing;Electrical instrumentation manufacturing;Intelligent Instrument Manufacturing;mold making(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Drug Wholesale;Health food sales(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research and development, manufacture, distribution, and retail of pharmaceutical products. The company was founded on January 18, 1994 and is headquartered in Shanghai, China.

ounded in 2014, Wuhan Bio-Raid Biotechnology Co., Ltd. is a high-tech enterprise focusing on CAR-T cell immunotherapy. Bio-Raid has developed a number of patented technologies, and established a broad pipeline of CAR-T product candidates covering blood and solid tumors and HIV areas of significant unmet medical need.

Shanghai Dongxizhihui Biomedical Co., Ltd., established on 2018-05-31, The scope of business includes engaging in biotechnology,Medical Technology,medical technology,technology development in the field of information technology,technical consulting,Technical Services,technology transfer,business inquiries,drug development,Medical device research and development,operate,software development,system integration,Computer hardware and software and auxiliary equipment,Instrumentation,Sales of Office Supplies,Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Guangzhou Institutes of Biomedicine and Health (GIBH)，(simplified Chinese: 中国科学院广州生物医药与健康研究院; traditional Chinese: 中國科學院廣州生物醫藥與健康研究院; pinyin: Zhōngguó Kēxué yuan guangzhou sheng wu yi yao yu jian kang yan jiu yuan) affiliated with the Chinese Academy of Sciences, is a government-sponsored scientific research institution with independent legal jurisdiction. GIBH was established by the Chinese Academy of Sciences, Guangdong Provincial Government and Guangzhou Municipal Government. The managerial mechanism of GIBH is the responsibility of Director-General, under the authority of the board of trustees.

Part of CSPC Pharmaceutical Group Ltd., CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co., Ltd. is a company headquartered in China. The firm engages in pharmaceutical research and development.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Hrain Biotechnology Co., Ltd. engages in the research and development, and production of immune cell therapy products. It offers chimeric antigen receptor (CAR) T-cell therapy, chimeric antigen receptor-transduced natural killer (CAR-NK) cell therapy, dash chimeric antigen receptor (CAR) T-cell therapy. The company was founded by Pin Wang on July 20, 2015 and is headquartered in Shanghai, China.

Shenzhen Neptunus Medical Technology Research Institute Co., Ltd., established on 2016-06-07, Business scope includes general business items:biomedical products,Health Care Products,food,Research and Development of Cosmetics,technology transfer,Technical Services,technical consulting;Domestic Trade,Operating import and export business,Invest in business(Specific projects will be reported separately).(law,Administrative regulations,The State Council decides to prohibit and require approval before registration except for items),The licensing program is:Pharmaceutical commissioned production and commissioned sales;Health Care Products,food,Consignment production and sales of cosmetics.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shenyang Fuyang Pharmaceutical Technology Co., Ltd., established on 2016-11-17, Business scope includes drug research and development,retail;Drug R&D Technical Consulting,technology transfer,Technical Services;Business Management Consulting;Self-operated and agent import and export of various commodities and technologies,Except for the goods and technologies that the state restricts the company to operate or prohibits the import and export of.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

Mabwell Biotech is a Chinese innovative biopharmaceutical company based in Shanghai Zhangjiang Hi-Tech Park. Since its establishment in 2017, it has absorbed and newly established nine biopharmaceutical R&D and production enterprises. At present, the company focuses on the development and manufacturing of macromolecular drugs such as therapeutic monoclonal antibodies and long-acting recombinant proteins. There are more than thirty varieties of drugs at different stages of development covering tumor, autoimmunity, anti-infection and ophthalmic diseases. Among them, six of them have entered the clinical stage, and three of them are in Phase III clinical trials.